Ambu A/S

Copenhagen Stock Exchange AMBU-B.CO

Ambu A/S EBT Margin for the year ending September 30, 2024: 5.56%

Ambu A/S EBT Margin is 5.56% for the year ending September 30, 2024, a 26.53% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Ambu A/S EBT Margin for the year ending September 30, 2023 was 4.40%, a 79.31% change year over year.
Ambu A/S EBT Margin for the year ending September 30, 2022 was 2.45%, a -68.04% change year over year.
Ambu A/S EBT Margin for the year ending September 30, 2021 was 7.68%, a -14.98% change year over year.
Ambu A/S EBT Margin for the year ending September 30, 2020 was 9.03%, a -38.36% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Copenhagen Stock Exchange: AMBU-B.CO

Ambu A/S

CEO	Ms. Britt Meelby Jensen
IPO Date	Feb. 11, 2004
Location	Denmark
Headquarters	Baltorpbakken 13
Employees	5,196
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Key trends

Past 5 years